Omega Healthcare Investors, Inc. Logo

Omega Healthcare Investors, Inc.

0KBL.L

(0.0)
Stock Price

40,22 USD

3.99% ROA

9.06% ROE

30.07x PER

Market Cap.

10.187.218.890,00 USD

127.48% DER

6.78% Yield

33.03% NPM

Omega Healthcare Investors, Inc. Stock Analysis

Omega Healthcare Investors, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Omega Healthcare Investors, Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

6 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

7 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

10 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (0), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

Omega Healthcare Investors, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Omega Healthcare Investors, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Omega Healthcare Investors, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Omega Healthcare Investors, Inc. Revenue
Year Revenue Growth
1992 5.900.000
1993 20.800.000 71.63%
1994 37.800.000 44.97%
1995 61.400.000 38.44%
1996 73.127.000 16.04%
1997 90.820.000 19.48%
1998 108.738.000 16.48%
1999 122.375.000 11.14%
2000 275.793.000 55.63%
2001 257.618.000 -7.06%
2002 137.111.000 -87.89%
2003 86.267.000 -58.94%
2004 90.451.000 4.63%
2005 105.812.000 14.52%
2006 135.693.000 22.02%
2007 159.558.000 14.96%
2008 193.762.000 17.65%
2009 197.438.000 1.86%
2010 258.321.000 23.57%
2011 292.204.000 11.6%
2012 350.460.000 16.62%
2013 418.714.000 16.3%
2014 504.787.000 17.05%
2015 743.617.000 32.12%
2016 900.827.000 17.45%
2017 908.385.000 0.83%
2018 881.682.000 -3.03%
2019 928.830.000 5.08%
2020 892.381.000 -4.08%
2021 1.062.809.000 16.04%
2022 878.244.000 -21.02%
2023 968.128.000 9.28%
2023 949.740.000 -1.94%
2024 1.021.380.000 7.01%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Omega Healthcare Investors, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
1992 0
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Omega Healthcare Investors, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
1992 500.000
1993 1.800.000 72.22%
1994 2.700.000 33.33%
1995 3.600.000 25%
1996 4.008.000 10.18%
1997 4.636.000 13.55%
1998 5.365.000 13.59%
1999 6.120.000 12.34%
2000 6.425.000 4.75%
2001 10.383.000 38.12%
2002 6.285.000 -65.2%
2003 5.943.000 -5.75%
2004 6.213.000 4.35%
2005 8.587.000 27.65%
2006 13.744.000 37.52%
2007 11.086.000 -23.98%
2008 11.701.000 5.26%
2009 11.742.000 0.35%
2010 15.054.000 22%
2011 19.432.000 22.53%
2012 21.330.000 8.9%
2013 21.588.000 1.2%
2014 25.888.000 16.61%
2015 38.568.000 32.88%
2016 45.867.000 15.91%
2017 47.683.000 3.81%
2018 63.508.000 24.92%
2019 56.661.000 -12.08%
2020 58.441.000 3.05%
2021 63.172.000 7.49%
2022 67.928.000 7%
2023 81.148.000 16.29%
2023 81.504.000 0.44%
2024 88.592.000 8%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Omega Healthcare Investors, Inc. EBITDA
Year EBITDA Growth
1992 7.400.000
1993 26.600.000 72.18%
1994 51.200.000 48.05%
1995 87.400.000 41.42%
1996 69.119.000 -26.45%
1997 86.184.000 19.8%
1998 103.374.000 16.63%
1999 116.255.000 11.08%
2000 -13.859.000 938.84%
2001 40.644.000 134.1%
2002 27.017.000 -50.44%
2003 79.798.000 66.14%
2004 106.690.000 25.21%
2005 97.295.000 -9.66%
2006 111.389.000 12.65%
2007 146.686.000 24.06%
2008 156.489.000 6.26%
2009 162.320.000 3.59%
2010 236.982.000 31.51%
2011 291.558.000 18.72%
2012 329.159.000 11.42%
2013 395.026.000 16.67%
2014 476.220.000 17.05%
2015 697.463.000 31.72%
2016 845.288.000 17.49%
2017 856.801.000 1.34%
2018 811.798.000 -5.54%
2019 856.884.000 5.26%
2020 782.179.000 -9.55%
2021 906.890.000 13.75%
2022 722.687.000 -25.49%
2023 851.936.000 15.17%
2023 828.952.000 -2.77%
2024 974.476.000 14.93%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Omega Healthcare Investors, Inc. Gross Profit
Year Gross Profit Growth
1992 5.900.000
1993 20.800.000 71.63%
1994 37.800.000 44.97%
1995 61.400.000 38.44%
1996 73.127.000 16.04%
1997 90.820.000 19.48%
1998 108.738.000 16.48%
1999 122.375.000 11.14%
2000 275.793.000 55.63%
2001 257.618.000 -7.06%
2002 137.111.000 -87.89%
2003 86.267.000 -58.94%
2004 90.451.000 4.63%
2005 100.358.000 9.87%
2006 135.693.000 26.04%
2007 158.142.000 14.2%
2008 188.178.000 15.96%
2009 197.279.000 4.61%
2010 250.323.000 21.19%
2011 291.551.000 14.14%
2012 350.188.000 16.74%
2013 418.299.000 16.28%
2014 501.127.000 16.53%
2015 725.936.000 30.97%
2016 842.101.000 13.79%
2017 809.315.000 -4.05%
2018 851.843.000 4.99%
2019 912.689.000 6.67%
2020 878.617.000 -3.88%
2021 1.049.093.000 16.25%
2022 861.275.000 -21.81%
2023 941.628.000 8.53%
2023 934.715.000 -0.74%
2024 709.444.000 -31.75%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Omega Healthcare Investors, Inc. Net Profit
Year Net Profit Growth
1992 4.400.000
1993 11.600.000 62.07%
1994 17.800.000 34.83%
1995 23.000.000 22.61%
1996 34.590.000 33.51%
1997 44.851.000 22.88%
1998 76.209.000 41.15%
1999 19.671.000 -287.42%
2000 -49.557.000 139.69%
2001 -16.657.000 -197.51%
2002 -14.646.000 -13.73%
2003 23.030.000 163.6%
2004 16.738.000 -37.59%
2005 36.688.000 54.38%
2006 55.697.000 34.13%
2007 69.374.000 19.71%
2008 78.137.000 11.21%
2009 82.111.000 4.84%
2010 58.436.000 -40.51%
2011 52.606.000 -11.08%
2012 120.698.000 56.42%
2013 172.521.000 30.04%
2014 221.349.000 22.06%
2015 224.524.000 1.41%
2016 366.415.000 38.72%
2017 100.419.000 -264.89%
2018 281.578.000 64.34%
2019 341.123.000 17.46%
2020 159.327.000 -114.1%
2021 416.739.000 61.77%
2022 426.927.000 2.39%
2023 365.524.000 -16.8%
2023 242.180.000 -50.93%
2024 455.448.000 46.83%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Omega Healthcare Investors, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1992 1
1993 2 100%
1994 2 0%
1995 1 0%
1996 2 50%
1997 2 0%
1998 3 33.33%
1999 1 0%
2000 -2 100%
2001 -1 0%
2002 0 0%
2003 0 0%
2004 -1 0%
2005 0 0%
2006 1 0%
2007 1 0%
2008 1 0%
2009 1 0%
2010 1 0%
2011 0 0%
2012 1 100%
2013 1 0%
2014 2 0%
2015 1 0%
2016 2 0%
2017 1 0%
2018 1 100%
2019 2 0%
2020 1 0%
2021 2 100%
2022 2 0%
2023 1 0%
2023 1 0%
2024 2 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Omega Healthcare Investors, Inc. Free Cashflow
Year Free Cashflow Growth
1992 5.500.000
1993 16.600.000 66.87%
1994 -5.700.000 391.23%
1995 21.800.000 126.15%
1996 36.265.000 39.89%
1997 -124.446.000 129.14%
1998 -87.761.000 -41.8%
1999 -5.532.000 -1486.42%
2000 19.492.000 128.38%
2001 15.906.000 -22.54%
2002 40.818.000 61.03%
2003 54.949.000 25.72%
2004 -65.458.000 183.95%
2005 -179.568.000 63.55%
2006 -122.901.000 -46.11%
2007 36.489.000 436.82%
2008 -40.890.000 189.24%
2009 -35.485.000 -15.23%
2010 -221.642.000 83.99%
2011 63.470.000 449.21%
2012 208.271.000 69.53%
2013 279.949.000 25.6%
2014 337.540.000 17.06%
2015 299.659.000 -12.64%
2016 556.808.000 46.18%
2017 491.223.000 -13.35%
2018 359.932.000 -36.48%
2019 414.069.000 13.07%
2020 633.145.000 34.6%
2021 627.072.000 -0.97%
2022 578.506.000 -8.4%
2023 171.020.000 -238.27%
2023 579.725.000 70.5%
2024 177.342.000 -226.9%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Omega Healthcare Investors, Inc. Operating Cashflow
Year Operating Cashflow Growth
1992 5.500.000
1993 16.600.000 66.87%
1994 27.700.000 40.07%
1995 44.800.000 38.17%
1996 54.886.000 18.38%
1997 60.431.000 9.18%
1998 69.713.000 13.31%
1999 74.312.000 6.19%
2000 19.492.000 -281.24%
2001 15.908.000 -22.53%
2002 41.545.000 61.71%
2003 56.453.000 26.41%
2004 54.362.000 -3.85%
2005 72.957.000 25.49%
2006 62.811.000 -16.15%
2007 84.542.000 25.7%
2008 89.328.000 5.36%
2009 147.223.000 39.32%
2010 157.563.000 6.56%
2011 169.771.000 7.19%
2012 208.271.000 18.49%
2013 279.949.000 25.6%
2014 337.540.000 17.06%
2015 463.885.000 27.24%
2016 625.791.000 25.87%
2017 577.912.000 -8.28%
2018 499.373.000 -15.73%
2019 553.747.000 9.82%
2020 708.256.000 21.82%
2021 722.136.000 1.92%
2022 625.727.000 -15.41%
2023 171.020.000 -265.88%
2023 617.736.000 72.32%
2024 184.411.000 -234.98%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Omega Healthcare Investors, Inc. Capital Expenditure
Year Capital Expenditure Growth
1992 0
1993 0 0%
1994 33.400.000 100%
1995 23.000.000 -45.22%
1996 18.621.000 -23.52%
1997 184.877.000 89.93%
1998 157.474.000 -17.4%
1999 79.844.000 -97.23%
2000 0 0%
2001 2.000 100%
2002 727.000 99.72%
2003 1.504.000 51.66%
2004 119.820.000 98.74%
2005 252.525.000 52.55%
2006 185.712.000 -35.98%
2007 48.053.000 -286.47%
2008 130.218.000 63.1%
2009 182.708.000 28.73%
2010 379.205.000 51.82%
2011 106.301.000 -256.73%
2012 0 0%
2013 0 0%
2014 0 0%
2015 164.226.000 100%
2016 68.983.000 -138.07%
2017 86.689.000 20.42%
2018 139.441.000 37.83%
2019 139.678.000 0.17%
2020 75.111.000 -85.96%
2021 95.064.000 20.99%
2022 47.221.000 -101.32%
2023 0 0%
2023 38.011.000 100%
2024 7.069.000 -437.71%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Omega Healthcare Investors, Inc. Equity
Year Equity Growth
1992 122.500.000
1993 122.700.000 0.16%
1994 338.500.000 63.75%
1995 347.100.000 2.48%
1996 383.007.000 9.38%
1997 468.221.000 18.2%
1998 505.762.000 7.42%
1999 457.081.000 -10.65%
2000 464.313.000 1.56%
2001 450.690.000 -3.02%
2002 479.701.000 6.05%
2003 436.235.000 -9.96%
2004 432.480.000 -0.87%
2005 429.681.000 -0.65%
2006 465.454.000 7.69%
2007 586.127.000 20.59%
2008 787.988.000 25.62%
2009 865.227.000 8.93%
2010 1.004.066.000 13.83%
2011 878.484.000 -14.3%
2012 1.011.329.000 13.14%
2013 1.300.103.000 22.21%
2014 1.401.327.000 7.22%
2015 4.100.865.000 65.83%
2016 4.211.986.000 2.64%
2017 3.888.258.000 -8.33%
2018 3.764.484.000 -3.29%
2019 4.336.594.000 13.19%
2020 4.036.607.000 -7.43%
2021 4.108.226.000 1.74%
2022 3.803.282.000 -8.02%
2023 3.857.330.000 1.4%
2023 3.762.291.000 -2.53%
2024 3.900.588.000 3.55%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Omega Healthcare Investors, Inc. Assets
Year Assets Growth
1992 144.800.000
1993 243.600.000 40.56%
1994 500.700.000 51.35%
1995 551.200.000 9.16%
1996 634.836.000 13.17%
1997 816.108.000 22.21%
1998 1.032.645.000 20.97%
1999 1.013.851.000 -1.85%
2000 948.451.000 -6.9%
2001 890.839.000 -6.47%
2002 802.620.000 -10.99%
2003 725.054.000 -10.7%
2004 833.563.000 13.02%
2005 1.015.729.000 17.93%
2006 1.175.370.000 13.58%
2007 1.182.287.000 0.59%
2008 1.364.467.000 13.35%
2009 1.655.033.000 17.56%
2010 2.304.007.000 28.17%
2011 2.572.687.000 10.44%
2012 2.982.005.000 13.73%
2013 3.462.216.000 13.87%
2014 3.921.645.000 11.72%
2015 8.019.009.000 51.1%
2016 8.949.260.000 10.39%
2017 8.773.305.000 -2.01%
2018 8.590.877.000 -2.12%
2019 9.796.124.000 12.3%
2020 9.497.449.000 -3.14%
2021 9.638.478.000 1.46%
2022 9.405.163.000 -2.48%
2023 9.425.313.000 0.21%
2023 9.117.402.000 -3.38%
2024 8.848.546.000 -3.04%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Omega Healthcare Investors, Inc. Liabilities
Year Liabilities Growth
1992 22.300.000
1993 120.900.000 81.56%
1994 162.200.000 25.46%
1995 204.100.000 20.53%
1996 251.829.000 18.95%
1997 347.887.000 27.61%
1998 526.883.000 33.97%
1999 556.770.000 5.37%
2000 484.138.000 -15%
2001 440.149.000 -9.99%
2002 322.919.000 -36.3%
2003 288.819.000 -11.81%
2004 401.083.000 27.99%
2005 586.048.000 31.56%
2006 709.916.000 17.45%
2007 596.160.000 -19.08%
2008 576.479.000 -3.41%
2009 789.806.000 27.01%
2010 1.299.941.000 39.24%
2011 1.694.203.000 23.27%
2012 1.970.676.000 14.03%
2013 2.162.113.000 8.85%
2014 2.520.318.000 14.21%
2015 3.918.144.000 35.68%
2016 4.737.274.000 17.29%
2017 4.885.047.000 3.03%
2018 4.826.393.000 -1.22%
2019 5.459.530.000 11.6%
2020 5.460.842.000 0.02%
2021 5.530.252.000 1.26%
2022 5.601.881.000 1.28%
2023 5.567.983.000 -0.61%
2023 5.355.111.000 -3.98%
2024 4.947.958.000 -8.23%

Omega Healthcare Investors, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
3.94
Net Income per Share
1.31
Price to Earning Ratio
30.07x
Price To Sales Ratio
10.37x
POCF Ratio
14.64
PFCF Ratio
16.07
Price to Book Ratio
2.66
EV to Sales
15.08
EV Over EBITDA
16.75
EV to Operating CashFlow
22.03
EV to FreeCashFlow
23.37
Earnings Yield
0.03
FreeCashFlow Yield
0.06
Market Cap
10,19 Bil.
Enterprise Value
14,82 Bil.
Graham Number
20.97
Graham NetNet
-18.96

Income Statement Metrics

Net Income per Share
1.31
Income Quality
2.03
ROE
0.09
Return On Assets
0.04
Return On Capital Employed
0.07
Net Income per EBT
0.94
EBT Per Ebit
0.63
Ebit per Revenue
0.56
Effective Tax Rate
0.03

Margins

Sales, General, & Administrative to Revenue
0.07
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.04
Gross Profit Margin
0.75
Operating Profit Margin
0.56
Pretax Profit Margin
0.35
Net Profit Margin
0.33

Dividends

Dividend Yield
0.07
Dividend Yield %
6.78
Payout Ratio
2.01
Dividend Per Share
2.68

Operating Metrics

Operating Cashflow per Share
2.7
Free CashFlow per Share
2.54
Capex to Operating CashFlow
0.06
Capex to Revenue
0.04
Capex to Depreciation
0.13
Return on Invested Capital
0.08
Return on Tangible Assets
0.04
Days Sales Outstanding
89.44
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
4.08
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0.16

Balance Sheet

Cash per Share
0,16
Book Value per Share
15,64
Tangible Book Value per Share
13.06
Shareholders Equity per Share
14.88
Interest Debt per Share
19.88
Debt to Equity
1.27
Debt to Assets
0.53
Net Debt to EBITDA
5.24
Current Ratio
5.54
Tangible Asset Value
3,26 Bil.
Net Current Asset Value
-2,97 Bil.
Invested Capital
8142783000
Working Capital
1,62 Bil.
Intangibles to Total Assets
0.07
Average Receivables
0,24 Bil.
Average Payables
0,00 Bil.
Average Inventory
0.5
Debt to Market Cap
0.46

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Omega Healthcare Investors, Inc. Dividends
Year Dividends Growth
2018 1
2023 3 50%
2024 2 0%

Omega Healthcare Investors, Inc. Profile

About Omega Healthcare Investors, Inc.

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.

CEO
Mr. C. Taylor Pickett CPA
Employee
57
Address
303 International Circle
Hunt Valley, 21030

Omega Healthcare Investors, Inc. Executives & BODs

Omega Healthcare Investors, Inc. Executives & BODs
# Name Age
1 Mr. Matthew P. Gourmand
Senior Vice President of Corporate Strategy & Investor Relations
70
2 Mr. Daniel J. Booth
Secretary & Chief Operating Officer
70
3 Mr. Neal Alexander Ballew
Senior Vice President & Chief Accounting Officer
70
4 Ms. Gail Dave Makode
Chief Legal Officer & General Counsel
70
5 Mr. Robert O. Stephenson
Chief Financial Officer, Treasurer & Assistant Secretary
70
6 Mr. Vikas Gupta
Senior Vice President of Acquisitions & Development
70
7 Mr. C. Taylor Pickett CPA
Chief Executive Officer & Director
70
8 Ms. Megan M. Krull
Senior Vice President of Operations
70
9 Michele Reber
Senior Director of Asset Management
70

Omega Healthcare Investors, Inc. Competitors

NCR Corporation Logo
NCR Corporation

0K45.L

(0.0)
Vornado Realty Trust Logo
Vornado Realty Trust

0LR2.L

(0.0)
Fluor Corporation Logo
Fluor Corporation

0IQC.L

(0.0)
Hanesbrands Inc. Logo
Hanesbrands Inc.

0J2X.L

(0.0)